Oral adverse events following COVID-19 and influenza
vaccination in Australia

J 2023

Oral adverse events following COVID-19 and influenza vaccination in Australia

RIAD, Abanoub; Julien ISSA; Sameh ATTIA; Ladislav DUŠEK; Miloslav KLUGAR et al.

Základní údaje

Originální název

Oral adverse events following COVID-19 and influenza vaccination in Australia

Autoři

RIAD, Abanoub; Julien ISSA; Sameh ATTIA; Ladislav DUŠEK a Miloslav KLUGAR

Vydání

HUMAN VACCINES & IMMUNOTHERAPEUTICS, PHILADELPHIA, TAYLOR & FRANCIS INC, 2023, 2164-5515

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.100

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/23:00132068

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

COVID-19 vaccines; drug-related side effects and adverse reactions; herpes zoster; pharmacovigilance; taste disorders

Štítky

14110525, 14119612, 14119613, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 30. 10. 2023 15:04, Mgr. Tereza Miškechová

Anotace

V originále

Vaccine hesitancy, spurred by misinterpretation of Adverse Events (AEs), threatens public health. Despite sporadic reports of oral AEs post-COVID-19 vaccination, systematic analysis is scarce. This study evaluates these AEs using the Australian Database of Adverse Event Notifications (DAEN). A secondary analysis of DAEN data was conducted, with the analysis period commencing from the start of the COVID-19 vaccination rollout in February 2021 and the inception of the influenza vaccine database in 1971, both through until December 2022. The focus of the analysis was on oral AEs related to COVID-19 and influenza vaccines. Reports were extracted according to a predefined schema and then stratified by vaccine type, sex, and age. Oral paresthesia was the most common oral AE after COVID-19 vaccination (75.28 per 10,000 reports), followed by dysgeusia (73.96), swollen tongue (51.55), lip swelling (49.43), taste disorder (27.32), ageusia (25.85), dry mouth (24.75), mouth ulceration (18.97), oral hypoaesthesia (15.60), and oral herpes (12.74). While COVID-19 and influenza vaccines shared most oral AEs, taste-related AEs, dry mouth, and oral herpes were significantly more common after COVID-19 vaccination. mRNA vaccines yielded more oral AEs than other types. Females had higher oral AE incidence. Most oral AEs did not differ significantly between COVID-19 and influenza vaccination. However, specific oral AEs, particularly taste-related, dry mouth, and oral herpes, were more prevalent after COVID-19 vaccination compared with seasonal influenza, especially in females and mRNA vaccine recipients.

Návaznosti

LX22NPO5101, projekt VaV

Název: Národní institut pro výzkum socioekonomických dopadů nemocí a systémových rizik (Akronym: SYRI)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní institut pro výzkum socioekonomických dopadů nemocí a systémových rizik, 5.1 EXCELES

Přiložené soubory

Oral_adverse_events_following_COVID-19_and_influenza_vaccination_in_Australia.pdf Verze souboru

Citovat

RIAD, Abanoub; Julien ISSA; Sameh ATTIA; Ladislav DUŠEK a Miloslav KLUGAR. Oral adverse events following COVID-19 and influenza vaccination in Australia. HUMAN VACCINES & IMMUNOTHERAPEUTICS. PHILADELPHIA: TAYLOR & FRANCIS INC, 2023, roč. 19, č. 2, s. 1-14. ISSN 2164-5515. Dostupné z: https://doi.org/10.1080/21645515.2023.2253589.

@article{2332085,
   author = {Riad, Abanoub and Issa, Julien and Attia, Sameh and Dušek, Ladislav and Klugar, Miloslav},
   article_location = {PHILADELPHIA},
   article_number = {2},
   doi = {https://doi.org/10.1080/21645515.2023.2253589},
   keywords = {COVID-19 vaccines; drug-related side effects and adverse reactions; herpes zoster; pharmacovigilance; taste disorders},
   language = {eng},
   issn = {2164-5515},
   journal = {HUMAN VACCINES & IMMUNOTHERAPEUTICS},
   title = {Oral adverse events following COVID-19 and influenza vaccination in Australia},
   url = {https://www.tandfonline.com/doi/full/10.1080/21645515.2023.2253589},
   volume = {19},
   year = {2023}
}

TY  - JOUR
ID  - 2332085
AU  - Riad, Abanoub - Issa, Julien - Attia, Sameh - Dušek, Ladislav - Klugar, Miloslav
PY  - 2023
TI  - Oral adverse events following COVID-19 and influenza vaccination in Australia
JF  - HUMAN VACCINES & IMMUNOTHERAPEUTICS
VL  - 19
IS  - 2
SP  - 1-14
EP  - 1-14
PB  - TAYLOR & FRANCIS INC
SN  - 21645515
KW  - COVID-19 vaccines
KW  - drug-related side effects and adverse reactions
KW  - herpes zoster
KW  - pharmacovigilance
KW  - taste disorders
UR  - https://www.tandfonline.com/doi/full/10.1080/21645515.2023.2253589
N2  - Vaccine hesitancy, spurred by misinterpretation of Adverse Events (AEs), threatens public health. Despite sporadic reports of oral AEs post-COVID-19 vaccination, systematic analysis is scarce. This study evaluates these AEs using the Australian Database of Adverse Event Notifications (DAEN). A secondary analysis of DAEN data was conducted, with the analysis period commencing from the start of the COVID-19 vaccination rollout in February 2021 and the inception of the influenza vaccine database in 1971, both through until December 2022. The focus of the analysis was on oral AEs related to COVID-19 and influenza vaccines. Reports were extracted according to a predefined schema and then stratified by vaccine type, sex, and age. Oral paresthesia was the most common oral AE after COVID-19 vaccination (75.28 per 10,000 reports), followed by dysgeusia (73.96), swollen tongue (51.55), lip swelling (49.43), taste disorder (27.32), ageusia (25.85), dry mouth (24.75), mouth ulceration (18.97), oral hypoaesthesia (15.60), and oral herpes (12.74). While COVID-19 and influenza vaccines shared most oral AEs, taste-related AEs, dry mouth, and oral herpes were significantly more common after COVID-19 vaccination. mRNA vaccines yielded more oral AEs than other types. Females had higher oral AE incidence. Most oral AEs did not differ significantly between COVID-19 and influenza vaccination. However, specific oral AEs, particularly taste-related, dry mouth, and oral herpes, were more prevalent after COVID-19 vaccination compared with seasonal influenza, especially in females and mRNA vaccine recipients.
ER  -

RIAD, Abanoub; Julien ISSA; Sameh ATTIA; Ladislav DUŠEK a Miloslav KLUGAR. Oral adverse events following COVID-19 and influenza vaccination in Australia. \textit{HUMAN VACCINES \&{}amp; IMMUNOTHERAPEUTICS}. PHILADELPHIA: TAYLOR \&{} FRANCIS INC, 2023, roč.~19, č.~2, s.~1-14. ISSN~2164-5515. Dostupné z: https://doi.org/10.1080/21645515.2023.2253589.

Přehled o publikaci